Opticyte, Inc. — Form D

Opticyte, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-12. The offering totals $2.3M, of which $72K was reported sold. Industry: Biotechnology.

Offering

Filed: 2017-10-12
Form: D
Accession: 0001718984-17-000002
Industry: Biotechnology
Exemptions: 06b
Total offering: $2.3M
Amount sold: $72K
Remaining: $2.2M
Investors: 2
Date of first sale: 2017-09-28
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-296546

Issuer

Name: Opticyte, Inc.
CIK: 0001718984
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2016
Address: 4000 MASON ROAD, SUITE 300, SEATTLE, WA, 98195
Phone: 206-775-5525

Officers, directors & promoters (9)

Name	Role	Location
Lorilee Arakaki	Director	Seattle, WA
Robert Masterson	Director	Seattle, WA
Kenneth Schenkman	Director	Seattle, WA
Lorilee Arakaki	Executive Officer	Seattle, WA
Robert Masterson	Executive Officer	Seattle, WA
Kenneth Schenkman	Executive Officer	Seattle, WA
Lorilee Arakaki	Promoter	Seattle, WA
Robert Masterson	Promoter	Seattle, WA
Kenneth Schenkman	Promoter	Seattle, WA

More